September 23, 2021
Pharmaceutical Packaging

Pharmaceutical Packaging Market to Grow Nearly 8.6% through 2027

Precedence Research has published a new report titled Pharmaceutical Packaging Market (By Product: Tertiary Pharmaceutical Packaging, Secondary Pharmaceutical Packaging, and Primary Pharmaceutical Packaging; By Material: Paper & Paperboard, Plastics & Polymers, Glass, Aluminum Foil, and Others; By End-use: Retail Pharmacy, Pharmaceutical Manufacturing, Institutional Pharmacy, Contract Packaging, and Others) – Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2020 – 2027″, the global pharmaceutical packaging market size is expected to grow US$ 191.21 Billion by 2027, decelerating at a CAGR of over 8.6% from 2020 to 2027. The report contains 150+ pages with detailed analysis.

The global pharmaceutical packaging market research report gives a brief summary of definitions, size analysis and place of production, sales, applications, types, and major players/key vendors of the pharmaceutical packaging industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies. The report provides the overall revenue of the global pharmaceutical packaging Market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

Market Estimations:

Market Was Valued In 2019 US$ 98.83 Billion
Market Is Projected To Grow By 2027 US$ 191.21 Billion
Compound Annual Growth Rate (CAGR) 8.6 percent from 2020 to 2027

Pharmaceutical packaging is commonly defined as the packaging materials used for packaging of pharmaceutical products. These materials are manufactured using drug-compatible materials that provide identification, protection, as well as ensure the reliability of the enclosed drug. Primary and secondary solutions of packaging are largely used to protect the enclosed product from biological, chemical, mechanical, and climatic hazards.

Blisters, bottles, caps & closures, labels & accessories, pouches & strip packs, pre-filled syringes, vials, pre-filled inhalers, jars & canisters, ampoules medication tubes, and cartridges are  part of the primary packaging product segment. However, secondary packaging solutions include paperboard boxes and temperature-controlled packaging. Pharmaceutical packaging products are manufactured using a variety of raw materials that include paper & paperboards, plastics & polymers, aluminum foil, glass, and others. Primary packaging products are made using materials for example glass, plastics & polymers, and aluminum foil.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1136

Growth Factors

Growing pharmaceutical industry especially in the developing countries because of high spending on healthcare infrastructure growth along with rising health awareness in the countries expected to prominently drive the market growth. Further, increasing demand for patient-oriented drugs and medicines is the other most important factor that triggers the demand for pharmaceutical packaging solution.

Demographic trends that include rising population along with rapid aging of population expected to fuel the requirement for pharmaceutical products, thereby propels the growth for pharmaceutical packaging solution over the analysis period. In addition, increasing demand for generic drugs because of their affordability along with development of new drugs further projected to drive the market growth for pharmaceutical packaging during the forthcoming years.

Various packing solutions used for pharmaceuticals effectively prevent the contamination as well as they offer drug safety along with the convenience in transportation and handling. Hence, pharmaceutical packaging is required for balancing several complex factors. Apart from this, high cost of these packaging solutions due to anti-counterfeiting efforts and stringent regulations is likely to hamper the market growth. Thus, rising packaging costs is one of the major challenges faced by the manufacturers of pharmaceutical packaging solutions.

Report Highlights

  • North America led the global market and account for a value share of around 38% in 2019 due to significant presence of leading pharmaceutical players in the region
  • The Asia Pacific projected to witness the fastest growth rate of nearly 12% over the forthcoming years owing to rapidly increasing population along with steady economic growth in the region
  • Primary pharmaceutical packaging product segment captured the maximum value share of nearly 75% and projected to retain its position over the analysis period
  • The secondary product segment projected to witness a CAGR of approximately 7.5% over the forecast period owing to significant usage in logistics &transportation
  • In 2019, pharmaceutical manufacturing held the largest revenue share of around 36% and projected to maintain the same trend over the forthcoming years due to increasing demand for better medical facilities
  • Increasing preference for outsourcing service rather than investing on the establishment of packaging infrastructure projected to propel the growth of contract packaging segment

COVID-19 Impact on pharmaceutical packaging Market Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the pharmaceutical packaging market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Precedence Research’s study predicts gradual recovery for the pharmaceutical packaging market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Related Reports

Regional Snapshots

North America is commonly known for the technological advancements along with product innovations that motivate drug manufacturers to offer advanced packaging solutions within the pharmaceutical industry. Major factors contributing towards the growth of the region include advancement in nanotechnology used for manufacturing processes coupled with the technological innovation, rising demand for blister packaging and drug delivery devices, to the pharmaceutical packaging market.

The United States anticipated being the largest pharmaceutical packaging market in North America because of its advanced drug production facility that commercializes new and sophisticated therapies that require specialized packaging solutions. However, the Asia Pacific expected to grow at a prominent rate over the analysis period owing to rising health awareness and disposable income in the region.

Key Players & Strategies

The global leaders in the pharmaceutical packaging industry are present on both regional and local level that turns the market into fragmented. Further, these market players are focusing prominently on the product development and enhancement. In the wake of same, they invest significantly on the R&D sector. This strategy of the leading industry participants also helps them to maintain their position as well as to grab maximum hold on the global market.

Some of the prominent players in the pharmaceutical packaging market include:

  • Becton, Dickinson and Company
  • Amcor Plc
  • AptarGroup, Inc.
  • Gerresheimer AG
  • Drug Plastics Group
  • Schott AG
  • West Pharmaceutical Services Inc.
  • Owens Illinois Inc.
  • Berry Global, Inc
  • SGD S.A.
  • WestRock Company
  • International Paper Company
  • CCL Industries Inc.
  • COMAR LLC
  • Vetter Pharma International

Segments Covered in the Report

By Product

  • Tertiary Pharmaceutical Packaging
  • Secondary Pharmaceutical Packaging
    • Pharmaceutical Packaging Accessories
    • Prescription Containers
  • Primary Pharmaceutical Packaging
    • Caps & Closures
    • Plastic Bottles
    • Parenteral Containers
    • Prefillable Inhalers
    • Blister Packs
    • Medication Tubes
    • Pouches
    • Others

By Material

  • Paper & Paperboard
  • Plastics & Polymers
    • Polyethylene (PE)
    • Polypropylene (PP)
    • Polyethylene Terephthalate (PET)
    • Polystyrene (PS)
    • Polyvinyl Chloride (PVC)
    • Others
  • Glass
  • Aluminum Foil
  • Others

By Application

  • Retail Pharmacy
  • Pharmaceutical Manufacturing
  • Institutional Pharmacy
  • Contract Packaging
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Pharmaceutical Packaging Market, By Product

7.1. Pharmaceutical Packaging Market, by Product Type, 2020-2027
7.1.1. Tertiary Pharmaceutical Packaging
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Secondary Pharmaceutical Packaging
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Primary Pharmaceutical Packaging
7.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Pharmaceutical Packaging Market, By Application

8.1. Pharmaceutical Packaging Market, by Application, 2020-2027
8.1.1. Retail Pharmacy
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Pharmaceutical Manufacturing
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Institutional Pharmacy
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Contract Packaging
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Pharmaceutical Packaging Market, By Material

9.1. Pharmaceutical Packaging Market, by Material, 2020-2027
9.1.1. Paper & Paperboard
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Plastics & Polymers
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Glass
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Aluminum Foil
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Pharmaceutical Packaging Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by Material (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Material (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Material (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by Material (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Material (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Material (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Material (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Material (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by Material (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Material (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Material (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Material (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Material (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by Material (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Material (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Material (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Material (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Material (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by Material (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Material (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Material (2016-2027)

Chapter 11. Company Profiles

11.1. Becton, Dickinson and Company
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Amcor Plc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AptarGroup, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Gerresheimer AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Drug Plastics Group
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Schott AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. West Pharmaceutical Services Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Owens Illinois Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Berry Global, Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. SGD S.A.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. WestRock Company
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. International Paper Company
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. CCL Industries Inc.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. COMAR LLC
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Vetter Pharma International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1136

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Bloghttps://precedenceresearchnews.wordpress.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →

Leave a Reply

Your email address will not be published. Required fields are marked *